Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Cancer Discovery|August 23, 2020
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Frank Ling, Camille Vaganay, et al.
Nature Communications|February 25, 2016
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agentsJane Merlevede, Nathalie Droin, Tingting Qin, et al.
Hemasphere|January 24, 2025
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromesDavid Rombaut, Sarah Sandmann, Tobias Tekath, et al.
Blood|September 2, 2020
A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemiaLaurène Fenwarth, Xavier Thomas, Stéphane de Botton, et al.
Blood|July 12, 2015
Disease evolution and outcomes in familial AML with germline CEBPA mutationsKiran Tawana, Jun Wang, Aline Renneville, et al.
American Journal of Hematology|July 29, 2020
Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: Data from 151 patientsJulien Rohmer, Amélie Couteau-Chardon, Julie Trichereau, et al.
Leukemia|January 16, 2024
Prognostic impact of CEBPA mutational subgroups in adult AMLJulia-Annabell Georgi, Sebastian Stasik, Michael Kramer, et al.
NEJM Evidence|June 24, 2025
Intermediate-Dose Cytarabine as Postinduction AML TherapyMathilde Hunault, Cécile Pautas, Sarah Bertoli, et al.
Haematologica|October 15, 2020
Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscapeLoria Zalmaï, Pierre-Julien Viailly, Sabeha Biichle, et al.
Leukemia|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangementBenoit Ducourneau, Arnaud Pages, Stéphanie Struski, et al.
Pageof 22